286 related articles for article (PubMed ID: 35618480)
1. Repetitive Early
Glatting FM; Hoppner J; Liew DP; van Genabith A; Spektor AM; Steinbach L; Hubert A; Kratochwil C; Giesel FL; Dendl K; Rathke H; Kauczor HU; Huber PE; Haberkorn U; Röhrich M
J Nucl Med; 2022 Dec; 63(12):1844-1851. PubMed ID: 35618480
[No Abstract] [Full Text] [Related]
2. Subclass Analysis of Malignant, Inflammatory and Degenerative Pathologies Based on Multiple Timepoint FAPI-PET Acquisitions Using FAPI-02, FAPI-46 and FAPI-74.
Glatting FM; Hoppner J; Kauczor HU; Huber PE; Kratochwil C; Giesel FL; Haberkorn U; Röhrich M
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358720
[TBL] [Abstract][Full Text] [Related]
3. Comparison of early and late
Hoppner J; van Genabith L; Hielscher T; Heger U; Sperling L; Colbatzky T; Gutjahr E; Lang M; Pausch T; Spektor AM; Glatting FM; Liermann J; Hackert T; Kratochwil C; Giesel FL; Haberkorn U; Röhrich M
Sci Rep; 2023 Oct; 13(1):17848. PubMed ID: 37857656
[TBL] [Abstract][Full Text] [Related]
4. [
Hu K; Wang L; Wu H; Huang S; Tian Y; Wang Q; Xiao C; Han Y; Tang G
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2833-2843. PubMed ID: 34893920
[TBL] [Abstract][Full Text] [Related]
5. Radiation Dosimetry and Biodistribution of
Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J
J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685
[TBL] [Abstract][Full Text] [Related]
6.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
7.
Dendl K; Koerber SA; Finck R; Mokoala KMG; Staudinger F; Schillings L; Heger U; Röhrich M; Kratochwil C; Sathekge M; Jäger D; Debus J; Haberkorn U; Giesel FL
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4089-4100. PubMed ID: 34050777
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study.
Röhrich M; Leitz D; Glatting FM; Wefers AK; Weinheimer O; Flechsig P; Kahn N; Mall MA; Giesel FL; Kratochwil C; Huber PE; Deimling AV; Heußel CP; Kauczor HU; Kreuter M; Haberkorn U
J Nucl Med; 2022 Jan; 63(1):127-133. PubMed ID: 34272325
[TBL] [Abstract][Full Text] [Related]
10. Three-Time-Point PET Analysis of
Naeimi M; Choyke PL; Dendl K; Mori Y; Staudinger F; Watabe T; Koerber SA; Röhrich M; Debus J; Kratochwil C; Haberkorn U; Giesel FL
J Nucl Med; 2023 Apr; 64(4):618-622. PubMed ID: 36357183
[TBL] [Abstract][Full Text] [Related]
11. Dual-tracer PET/CT protocol with [
Wegen S; Weindler J; Voltin CA; van Heek L; Schomäcker K; Fischer T; Marnitz S; Kobe C; Drzezga A; Roth KS
Strahlenther Onkol; 2024 Jan; 200(1):28-38. PubMed ID: 37584717
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of acquisitions using total-body PET/CT with a half-dose [
Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
[TBL] [Abstract][Full Text] [Related]
13. The earliest optimal timing for total-body
Zheng Z; Gao H; Lin Y; Yu H; Mao W; Yang R; He Y; Chen X; Wu H; Hu P; Shi H
Eur Radiol; 2023 Dec; ():. PubMed ID: 38110627
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of [
Unterrainer LM; Lindner S; Eismann L; Casuscelli J; Gildehaus FJ; Bui VN; Albert NL; Holzgreve A; Beyer L; Todica A; Brendel M; Cyran CC; Karl A; Stief CG; Ledderose ST; Unterrainer M; Bartenstein P; Wenter V; Kretschmer A
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3571-3580. PubMed ID: 35325283
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution, pharmacokinetics, dosimetry of [
Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
[TBL] [Abstract][Full Text] [Related]
18. Head-to-head Intra-individual Comparison of [
Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
[TBL] [Abstract][Full Text] [Related]
19. Tumor Characterization by [
Rasinski P; Af Burén S; Holstensson M; Nilsson T; Loizou L; Tran TA; Sparrelid E; Löhr JM; Axelsson R
J Nucl Med; 2023 Aug; 64(8):1232-1237. PubMed ID: 37348917
[TBL] [Abstract][Full Text] [Related]
20.
Kratochwil C; Flechsig P; Lindner T; Abderrahim L; Altmann A; Mier W; Adeberg S; Rathke H; Röhrich M; Winter H; Plinkert PK; Marme F; Lang M; Kauczor HU; Jäger D; Debus J; Haberkorn U; Giesel FL
J Nucl Med; 2019 Jun; 60(6):801-805. PubMed ID: 30954939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]